Brivanib (alaninate)
Brivanib Alaninate (BMS-582664) is a VEGFR2 kinase inhibitor salt formulated for research. It suppresses tumor angiogenesis and growth by selectively targeting VEGFR2, as demonstrated in studies investigating hepatocellular carcinoma and colorectal cancer models both in vitro and in vivo.
Product Specifications
CAS Number
649735-63-7
Product Name Alternative
Brivanib, Brivanib (alaninate), Brivanib Alaninate, BMS 582664, BMS582664, BMS-582664, Autophagy, alaninate, inhibit, Inhibitor, Flk1, FGFR1, Vascular endothelial growth factor receptor, VEGFR2, VEGFR1, VEGFR
Field of Research
Cardiovascular Research, Cell Biology, Signal Transduction
Purity
99.23% (May vary between batches)
Solubility
Ethanol:82 mg/mL (185.75 mM) ;10% DMSO+90% Corn Oil:3.3 mg/mL (7.48 mM) ; DMSO:82 mg/mL (185.75 mM)
Smiles
C[C@H] (COc1cn2ncnc (Oc3ccc4[nH]c (C) cc4c3F) c2c1C) OC (=O) [C@H] (C) N
Molecular Formula
C22H24FN5O4
Molecular Weight
441.46
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
A00171-Fluoro594 100 µg/Vial
Anti-ICAM1 Antibody Picoband® Fluoro594 Conjugated
Sign In for Pricing
View Details 
357978-01 48 Tests
PDGFD (Platelet Derived Growth Factor D) BioAssayTM ELISA Kit (Mouse) discontinued
Sign In for Pricing
View Details 357978-02 96 Tests
PDGFD (Platelet Derived Growth Factor D) BioAssayTM ELISA Kit (Mouse) discontinued
Sign In for Pricing
View Details